HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A multicenter, randomized controlled clinical study on biapenem and imipenem/cilastatin injection in the treatment of respiratory and urinary tract infections.

AbstractBACKGROUND:
Biapenem is an injectable carbapenem antibiotic. A clinical study was designed to evaluate its efficacy and safety in the treatment of respiratory and urinary infections compared to imipenem/cilastatin.
METHODS:
A total of 216 patients with respiratory or urinary tract infections were enrolled into this multicenter, open-label, randomized controlled clinical study. Each patient was randomly assigned to either the treatment or control group; 106 patients in each group were included in the ITT analyses. The patients were given biapenem 300 mg or imipenem/cilastatin 500 mg/500 mg two or three times daily, i.v. g.t.t. for 7-14 days according to their conditions.
RESULTS:
The cure and effective rates were 67.92 and 88.68% in the biapenem group and 76.02 and 93.40% in the imipenem/cilastatin group, the bacterial eradication rates were 93.83 and 98.82%, and the adverse-event rates were 6.54 and 7.41%, respectively. There were no significant differences between the two groups (p > 0.05).
CONCLUSION:
Biapenem is as effective and well-tolerated as imipenem/cilastatin for the treatment of intermediate and severe bacterial infections.
AuthorsBei Jia, Ping Lu, Wenxiang Huang, Chongzhi Li, Ailong Huang, Xiangdong Zhou, Weili Zhang, Guoming Wu, Genfu Zhang
JournalChemotherapy (Chemotherapy) Vol. 56 Issue 4 Pg. 285-90 ( 2010) ISSN: 1421-9794 [Electronic] Switzerland
PMID20714145 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
CopyrightCopyright © 2010 S. Karger AG, Basel.
Chemical References
  • Anti-Infective Agents
  • Drug Combinations
  • Thienamycins
  • Cilastatin
  • Imipenem
  • Cilastatin, Imipenem Drug Combination
  • biapenem
Topics
  • Adolescent
  • Adult
  • Aged
  • Anti-Infective Agents (adverse effects, pharmacology, therapeutic use)
  • Bacterial Infections (drug therapy, microbiology)
  • Cilastatin (adverse effects, pharmacology, therapeutic use)
  • Cilastatin, Imipenem Drug Combination
  • Drug Combinations
  • Female
  • Hospitals, Teaching
  • Humans
  • Imipenem (adverse effects, pharmacology, therapeutic use)
  • Male
  • Middle Aged
  • Respiratory Tract Infections (drug therapy, microbiology)
  • Thienamycins (adverse effects, pharmacology, therapeutic use)
  • Urinary Tract Infections (drug therapy, microbiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: